Next Article in Journal
Mackerel-Derived Fermented Fish Oil Promotes Hair Growth by Anagen-Stimulating Pathways
Next Article in Special Issue
Involvement of NOS2 Activity on Human Glioma Cell Growth, Clonogenic Potential, and Neurosphere Generation
Previous Article in Journal
F13A1 Gene Variant (V34L) and Residual Circulating FXIIIA Levels Predict Short- and Long-Term Mortality in Acute Myocardial Infarction after Coronary Angioplasty
Previous Article in Special Issue
The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas
Article Menu
Issue 9 (September) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2018, 19(9), 2768;

Drug Repurposing of Metabolic Agents in Malignant Glioma

Department of Neurology and Wilhelm Sander-NeuroOncology Unit, University Hospital Regensburg, 93053 Regensburg, Germany
Author to whom correspondence should be addressed.
Received: 15 August 2018 / Revised: 10 September 2018 / Accepted: 11 September 2018 / Published: 14 September 2018
Full-Text   |   PDF [232 KB, uploaded 14 September 2018]   |  


Gliomas are highly invasive brain tumors with short patient survival. One major pathogenic factor is aberrant tumor metabolism, which may be targeted with different specific and unspecific agents. Drug repurposing is of increasing interest in glioma research. Drugs interfering with the patient’s metabolism may also influence glioma metabolism. In this review, we outline definitions and methods for drug repurposing. Furthermore, we give insights into important candidates for a metabolic drug repurposing, namely metformin, statins, non-steroidal anti-inflammatory drugs, disulfiram and lonidamine. Advantages and pitfalls of drug repurposing will finally be discussed. View Full-Text
Keywords: glioma; glioblastoma; drug repurposing; metformin; statin; NSAR; disulfiram; lonidamine glioma; glioblastoma; drug repurposing; metformin; statin; NSAR; disulfiram; lonidamine

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Seliger, C.; Hau, P. Drug Repurposing of Metabolic Agents in Malignant Glioma. Int. J. Mol. Sci. 2018, 19, 2768.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top